Our findings demonstrate that inhibition of the NFκB signaling pathway in MEC tumors is an effective therapeutic strategy to sensitize tumor cells to radiation independent of the initial resistance of each cell line to radiation. The gene discussed is NFKB1; the disease is neoplasm.